Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors

The optimal treatment of recurrent ovarian granulosa cell tumors is not known. Pre-clinical studies and small case series have suggested direct anti-tumor activity of gonadotropin-releasing hormone agonists in the treatment of this disease, but little is known about the efficacy and safety of this approach.

Source: American Journal of Obstetrics and Gynecology - March 9, 2023 Category: OBGYN Authors: Katherine I. Foster, Alejandra Flores legarreta, Rhea Kamat, Katelyn F. Handley, Deanna Glassman, Jeffrey A. How, Barrett C. Lawson, Shannon N. Westin, Lois M. Ramondetta, Michael Frumovitz, David M. Gershenson, Anil K. Sood, R. Tyler Hillman Tags: Original Research: Gynecology Source Type: research